Alcoholic liver disease

K11_ALCOLIV

Hepatitis, Alcoholic: INFLAMMATION of the LIVER due to ALCOHOL ABUSE. It is characterized by NECROSIS of HEPATOCYTES, infiltration by NEUTROPHILS, and deposit of MALLORY BODIES. Depending on its severity, the inflammatory lesion may be reversible or progress to LIVER CIRRHOSIS.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K70 Hospital discharge: ICD-9 — 571[0-3] Hospital discharge: ICD-8 — 5710 Cause of death: ICD-10 — K70 Cause of death: ICD-9 — 571[0-3] Cause of death: ICD-8 — 5710 2 out of 7 registries used, show all original rules.	3853
4. Check minimum number of events None	3853
5. Include endpoints None	3853
6. Filter based on genotype QC (FinnGen only)	3853

Control definitions (FinnGen only)

Control exclude: K11_LIVER

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K70-K77
Name in latin: Morbus hepatis alcoholicus

NAME	K11_ALCOLIV
CONTROL_EXCLUDE	K11_LIVER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K70
HD_ICD_9	571[0-3]
HD_ICD_8	5710
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K70
COD_ICD_9	571[0-3]
COD_ICD_8	5710
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alcoholic liver disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	68208	15821	50693
Only index persons	38268	9865	28403
Unadjusted period prevalence (%)
Whole population	1.20	0.45	1.42
Only index persons	0.90	0.36	1.08
Median age at first event (years)
Whole population	55.72	56.23	55.54
Only index persons	57.44	57.56	57.40

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3853	951	2902
Unadjusted period prevalence (%)	1.04	0.32	1.28
Median age at first event (years)	58.57	56.46	59.26

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3413: Matched controls
34128

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

236.2

323.0

504

R18

ICD-10 Finland

Ascites

48.0

323.0

584

146

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

2127.1

323.0

400

A06AD11

ATC

lactulose; oral

5.7

323.0

1124

2717

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

5776.5

323.0

506

K70.4

ICD-10 Finland

Alcoholic hepatic failure

+∞

323.0

471

K70.0

ICD-10 Finland

Alcoholic fatty liver

851.4

323.0

738

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

16.4

323.0

1343

1295

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

17.2

323.0

559

384

K70.1

ICD-10 Finland

Alcoholic hepatitis

4895.4

323.0

787

C03DA01

ATC

spironolactone; oral

11.7

323.0

1382

1874

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.9

323.0

1771

6163

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

16384.0

323.0

1833

C03CA01

ATC

furosemide; systemic

4.1

305.6

1666

6385

P15

ICPC

Chronic alcohol abuse

14.6

297.9

524

418

F10.25

ICD-10 Finland

Alcohol dependence continuous use

20.6

289.0

443

245

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

7.1

277.9

751

1296

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.3

274.5

976

2383

F10.20

ICD-10 Finland

Alcohol dependence currently independent

18.1

273.2

439

276

N07BB01

ATC

disulfiram; oral

9.2

256.4

577

742

K92.0

ICD-10 Finland

Haematemesis

15.6

255.0

434

315

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

26.7

252.7

356

148

C07AA05

ATC

propranolol; systemic

4.5

244.3

1046

3055

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

628.3

240.0

235

F10.24

ICD-10 Finland

Alcohol depence active use

23.8

237.3

346

161

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

26.0

229.7

326

138

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

215.9

179.0

184

R56.8

ICD-10 Finland

Other and unspecified convulsions

7.1

174.7

460

733

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

14.5

174.0

304

229

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

17.1

171.9

280

177

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

16.9

168.5

276

177

K72.9

ICD-10 Finland

Hepatic failure, unspecified

+∞

163.9

156

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

12.9

161.4

297

251

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

15.6

159.3

269

186

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

17.6

156.0

251

153

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

7.6

155.6

387

563

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

22.9

153.0

225

105

N06AX11

ATC

mirtazapine; oral

2.8

147.6

1334

6426

F10.09

ICD-10 Finland

Alcohol intoxication UNS

10.4

145.1

297

310

N05BA02

ATC

chlordiazepoxide; systemic

8.7

144.3

327

409

K76.7

ICD-10 Finland

Hepatorenal syndrome

+∞

142.7

136

N05CF01

ATC

zopiclone; oral

2.6

140.6

1404

7121

K76.9

ICD-10 Finland

Liver disease, unspecified

169.3

139.6

146

D64.9

ICD-10 Finland

Anaemia, unspecified

3.9

134.7

633

1887

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

27.4

134.4

187

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

14.9

133.3

229

164

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.2

133.2

842

3167

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

+∞

131.1

125

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

14.3

129.5

226

168

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

+∞

125.8

120

A98

ICPC

Health maint/preventive medicine

0.4

124.5

2293

28862

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

21.6

124.4

186

N05AH04

ATC

quetiapine; oral

3.2

123.4

753

2742

N05BA04

ATC

oxazepam; oral

2.7

123.0

1052

4786

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

27.7

121.9

169

K92.1

ICD-10 Finland

Melaena

5.2

121.6

411

880

A07AA11

ATC

rifaximin; oral

255.0

120.7

123

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

19.8

119.6

184

E87.6

ICD-10 Finland

Hypokalaemia

8.4

116.8

270

346

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

19.7

114.3

176

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

114.0

837

3436

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

386.5

113.1

113

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.8

112.1

536

1602

N05BA01

ATC

diazepam; systemic, rectal

3.2

111.5

676

2432

P16

ICPC

Acute alcohol abuse

11.5

110.5

213

196

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

21.6

109.3

163

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.4

108.2

1220

6375

T36

ICD-10 Finland

Poisoning by systemic antibiotics

6.1

107.1

309

544

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

13.9

106.0

187

142

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.8

104.6

315

585

N06AB04

ATC

citalopram; systemic

2.7

104.5

904

4068

D97

ICPC

Liver disease NOS

50.5

100.8

122

Z72.1

ICD-10 Finland

Alcohol use

13.1

100.1

181

145

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

14.3

99.4

173

127

Z94.4

ICD-10 Finland

Liver transplant status

173.3

96.7

101

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

9.0

95.2

210

248

AA1AD

NOMESCO Finland

CT of head and brain

2.4

92.4

1030

5261

JJC00

NOMESCO Finland

Allogenic transplantation of liver

317.7

91.3

N05CD07

ATC

temazepam; oral

2.9

91.2

637

2490

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.3

90.3

1071

5626

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.7

89.6

240

381

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

28.5

88.2

121

5710A

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic fatty liver

+∞

85.8

S01.0

ICD-10 Finland

Open wound of scalp

3.4

83.5

446

1436

5712A

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic cirrhosis of liver

+∞

82.6

103

Kela drug reimbursment

Diabetes, insulin-treated

2.1

80.9

1177

6719

N05AB01

ATC

dixyrazine; systemic

9.5

79.4

169

187

N02AX02

ATC

tramadol; systemic, rectal

2.0

77.8

1631

10759

SPAT1265

SPAT

Breathalyser

13.4

76.9

137

106

A02BC02

ATC

pantoprazole; systemic

2.0

75.5

2250

16881

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

32.8

75.0

K29.2

ICD-10 Finland

Alcoholic gastritis

28.1

73.5

101

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

6.5

73.0

198

319

K72.1

ICD-10 Finland

Chronic hepatic failure

723.2

72.4

5711A

ICD-9 Finland

Chronic liver disease and cirrhosis, Acute alcoholic hepatitis

+∞

72.1

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

19.7

71.3

109

57101

ICD-8 Finland

Cirrhosis of liver, Degeneratio hepatica adiposa alcoholica

+∞

71.1

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

27.6

68.1

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

28.6

67.4

N06AB10

ATC

escitalopram; oral

2.4

66.1

662

3124

K85

ICD-10 Finland

Acute pancreatitis

7.2

65.7

166

242

B18.2

ICD-10 Finland

Chronic viral hepatitis C

14.6

65.5

112

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

64.9

713

3517

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

64.5

833

4428

57100

ICD-8 Finland

Cirrhosis of liver, Cirrhosis cum alcoholismo

+∞

60.6

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

313.1

60.5

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.3

58.9

322

1044

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.3

58.3

227

551

A10AE04

ATC

insulin glargine; parenteral

2.7

58.1

454

1860

V03AA01

ATC

5.9

57.4

167

294

JN3AD

NOMESCO Finland

Abdominal CT examination

2.9

56.1

368

1351

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.7

56.1

201

449

N06AX16

ATC

venlafaxine; oral

2.5

55.7

480

2074

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

55.6

466

1983

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.8

55.4

248

684

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.8

54.6

394

1535

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

54.3

317

1073

N05AA02

ATC

levomepromazine; systemic

3.9

54.2

241

660

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

7.1

54.1

137

200

W19

ICD-10 Finland

Unspecified fall

2.7

53.1

406

1637

K29.6

ICD-10 Finland

Other gastritis

9.3

52.7

112

124

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

52.2

1548

10955

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

17.5

51.6

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.5

51.6

445

1921

T90

ICPC

Diabetes non-insulin dependent

1.9

51.5

925

5531

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

22.2

50.6

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.9

50.4

172

365

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.8

49.9

344

1299

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

6.7

49.8

131

202

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.4

49.7

188

443

S42.2

ICD-10 Finland

Fracture of upper end of humerus

4.1

49.6

206

531

S06.0

ICD-10 Finland

Concussion

2.6

49.0

391

1614

A46

ICD-10 Finland

Erysipelas

2.2

48.5

597

3058

JJ5AT

NOMESCO Finland

484.5

48.5

WX892

NOMESCO Finland

Monitored bed care

2.7

47.7

358

1425

UJD02

NOMESCO Finland

Gastroscopy

3.5

47.6

241

734

M04AA01

ATC

allopurinol; systemic

2.1

47.6

604

3133

K70

ICD-10 Finland

Alcoholic liver disease

103.5

46.9

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

46.8

446

2019

WW500

NOMESCO Finland

Blood transfusion

3.7

46.5

216

614

N06AB03

ATC

fluoxetine; oral

2.4

46.2

450

2059

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

5.5

45.7

139

259

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

26.7

45.6

E87.2

ICD-10 Finland

Acidosis

14.3

44.9

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

22.8

44.9

TKC20

NOMESCO Finland

Catheterisation of bladder

2.7

44.8

344

1384

R53

ICD-10 Finland

Malaise and fatigue

2.0

44.5

661

3645

K86.1

ICD-10 Finland

Other chronic pancreatitis

9.1

44.3

107

R41.0

ICD-10 Finland

Disorientation, unspecified

4.2

44.2

178

446

SPAT1247

SPAT

Outpatient detoxication and monitoring

16.4

43.9

5713X

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic liver damage, unspecified

+∞

42.8

A10BA02

ATC

metformin; oral

1.8

42.8

1059

6967

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.8

42.7

295

1112

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

42.4

892

5564

N05CF02

ATC

zolpidem; oral

2.0

42.4

590

3166

A28

ICPC

Limited function/disability NOS

2.1

42.3

537

2774

TK800

NOMESCO Finland

Hemodialysis

4.8

42.1

147

320

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

7.4

41.9

102

141

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

41.3

268

973

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

40.9

451

2185

C07AG02

ATC

carvedilol; oral

2.8

40.6

279

1048

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

23.6

40.6

G93.4

ICD-10 Finland

Encephalopathy, unspecified

28.8

40.0

N05BA12

ATC

alprazolam; oral

2.4

39.4

371

1662

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

11.3

38.9

K86.0

ICD-10 Finland

Alcohol-induced chronic pancreatitis

47.6

38.8

127

Kela drug reimbursment

Transplant complication

6.4

38.8

105

169

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

38.5

1027

6862

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.1

38.2

125

254

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

38.2

219

731

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

38.1

919

5956

A10BH01

ATC

sitagliptin; oral

2.2

37.6

399

1896

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

37.4

236

839

V03AB30

ATC

8.5

37.0

SPAT1227

SPAT

Substance abuse rehabilitation

10.5

37.0

309

Kela drug reimbursment

Nalmefene and naltrexone

14.2

36.9

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

60.7

36.2

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

13.7

35.7

N06AA12

ATC

doxepin; systemic

2.9

35.7

225

798

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.6

35.7

128

287

N40

ICD-10 Finland

Hyperplasia of prostate

0.5

35.6

419

7123

K76.6

ICD-10 Finland

Portal hypertension

+∞

35.5

R11

ICD-10 Finland

Nausea and vomiting

2.7

35.3

261

1024

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.5

35.1

174

521

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

7.4

34.9

118

E86

ICD-10 Finland

Volume depletion

4.3

34.5

132

315

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

34.3

582

3342

S82.6

ICD-10 Finland

Fracture of lateral malleolus

2.8

34.0

233

871

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

6.7

33.9

134

SPAT1240

SPAT

Therapeutic discussion

2.5

33.8

290

1236

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

32.8

248

985

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

171.6

32.7

N06AB06

ATC

sertraline; oral

2.3

32.7

327

1506

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

10.5

32.6

A02BC01

ATC

omeprazole; systemic

1.7

32.5

892

5953

W10

ICD-10 Finland

Fall on and from stairs and steps

2.9

32.4

207

741

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

6.4

32.4

139

T74.1

ICD-10 Finland

Physical abuse

6.3

32.3

140

WX882

NOMESCO Finland

High dependency care

4.0

32.2

134

347

K29.7

ICD-10 Finland

Gastritis, unspecified

3.4

32.0

163

498

N17.8

ICD-10 Finland

Other acute renal failure

6.6

31.8

128

A09AA02

ATC

multienzymes (lipase, protease etc.)

4.2

31.5

124

305

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

31.3

624

3772

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

3.3

31.3

162

502

F05.9

ICD-10 Finland

Delirium, unspecified

4.3

31.3

120

288

K86.3

ICD-10 Finland

Pseudocyst of pancreas

10.3

30.8

N05BE01

ATC

buspirone; oral

3.6

30.7

146

423

G72.8

ICD-10 Finland

Other specified myopathies

5.1

30.6

199

L04AA06

ATC

mycophenolic acid; systemic

5.2

30.4

192

P03

ICPC

Feeling depressed

2.7

30.4

219

844

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

2.9

30.2

195

703

K74.3

ICD-10 Finland

Primary biliary cirrhosis

+∞

30.2

K74.0

ICD-10 Finland

Hepatic fibrosis

+∞

30.2

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

38.4

30.2

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.9

30.2

101

211

L28

ICPC

Limited function/disability (L)

1.9

29.8

501

2853

E87.5

ICD-10 Finland

Hyperkalaemia

5.2

29.8

188

N19

ICD-10 Finland

Unspecified kidney failure

3.3

29.8

154

477

N06AB05

ATC

paroxetine; oral

2.7

29.7

220

864

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

21.8

29.5

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

29.5

175

597

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

13.6

29.5

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.7

29.4

207

788

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

10.0

29.4

TJA10

NOMESCO Finland

Laparocentesis

24.4

29.2

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

29.0

363

1844

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

6.4

29.0

122

N06AX03

ATC

mianserin; oral

2.8

28.9

197

737

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

19.8

28.7

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.2

28.6

113

279

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

11.2

28.5

A12BA01

ATC

potassium chloride; oral

3.0

28.5

175

612

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

6.2

28.4

129

OAB43

SPAT

0.3

28.0

2242

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

16.3

28.0

M10.9

ICD-10 Finland

Gout, unspecified

2.2

27.7

292

1375

K65.0

ICD-10 Finland

Acute peritonitis

5.9

27.6

134

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

27.4

222

917

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

27.3

468

2677

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

7.2

27.0

A05AA02

ATC

ursodeoxycholic acid; oral

8.6

27.0

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.2

26.9

281

1316

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

26.8

205

819

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.1

26.6

107

269

R60.0

ICD-10 Finland

Localized oedema

2.0

26.2

365

1932

R4110

NOMESCO Finland

Physiotherapy

1.6

26.2

845

5828

S42.0

ICD-10 Finland

Fracture of clavicle

3.4

26.1

132

402

I86.4

ICD-10 Finland

Gastric varices

60.5

26.0

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.7

25.9

133

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

24.2

25.7

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

25.6

457

2649

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

33.3

25.5

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.9

25.5

157

549

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

25.4

424

2401

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

6.0

25.3

121

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

+∞

25.0

L04AD01

ATC

ciclosporin; systemic

4.4

24.9

214

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.7

24.9

187

F10.8

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Other mental and behavioural disorders

26.4

24.8

X58

ICD-10 Finland

Exposure to other specified factors

1.8

24.8

446

2591

JN4CD

NOMESCO Finland

Very extensive body CT

2.8

24.8

169

632

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

24.8

159

572

SPAT1254

SPAT

Administration of medicine

1.8

24.7

447

2601

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

6.5

24.7

102

JCA20

NOMESCO Finland

Ligature of oesophageal varices

251.9

24.7

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

15.5

24.6

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

4.0

24.4

101

261

E51.2

ICD-10 Finland

Wernicke encephalopathy

24.5

24.3

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

14.4

23.9

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.8

23.8

103

277

I85

ICD-10 Finland

Oesophageal varices

241.5

23.7

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

241.5

23.7

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.3

23.5

123

385

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

21.4

23.4

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

47.0

23.3

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

23.2

229

1047

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

23.0

546

3453

S97

ICPC

Chronic ulcer skin

2.3

22.7

213

948

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

7.2

22.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

22.6

445

2658

P76

ICPC

Depressive disorder

2.7

22.5

155

583

N05AD01

ATC

haloperidol; systemic

2.9

22.5

140

493

WX730

NOMESCO Finland

Conventional respirator

4.0

22.4

232

R01AD12

ATC

fluticasone furoate; nasal

0.6

22.3

329

5351

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

8.7

22.3

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

21.9

388

2237

N05AD03

ATC

melperone; systemic

4.6

21.9

171

P01

ICPC

Feeling anxious/nervous/tense

2.4

21.9

190

814

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

21.8

827

5886

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.8

21.7

141

513

2910A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal delirium

14.5

21.6

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.3

21.6

211

959

WX872

NOMESCO Finland

Intensive care

2.3

21.6

213

973

S22.3

ICD-10 Finland

Fracture of rib

2.1

21.5

255

1264

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.6

21.4

165

663

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.5

21.1

171

708

UJF32

NOMESCO Finland

Coloscopy

1.5

21.0

796

5662

F51.0

ICD-10 Finland

Nonorganic insomnia

1.9

20.9

321

1759

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

20.7

148

571

K05.31

ICD-10 Finland

Periodontitis pronounced

1.9

20.5

344

1943

J01MA02

ATC

ciprofloxacin; systemic

1.4

20.5

1251

9817

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.7

20.4

142

538

N02AA05

ATC

oxycodone; systemic

1.7

20.2

475

2984

N06AX05

ATC

trazodone; oral

3.5

20.2

275

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

4.3

20.1

173

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

7.1

19.8

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

5.4

19.7

110

F34.1

ICD-10 Finland

Dysthymia

3.1

19.7

113

378

ZX120

NOMESCO Finland

Intravenous

1.9

19.7

300

1638

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.6

19.6

145

570

4560A

ICD-9 Finland

Varicose veins of other sites, Oesophageal varices with bleeding

105.6

19.6

C07AB07

ATC

bisoprolol; oral

1.4

19.5

1521

12448

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

7.4

19.4

A10AE05

ATC

insulin detemir; parenteral

2.2

19.3

197

912

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.9

19.3

118

414

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.9

19.2

210

N05AF03

ATC

chlorprothixene; systemic

3.0

19.2

110

369

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

19.1

444

2777

A04

ICPC

Weakness/tiredness general

1.8

19.1

331

1893

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.0

19.1

112

382

205

Kela drug reimbursment

Chronic hypertension

1.5

19.0

935

7005

N03AX16

ATC

pregabalin; oral

1.5

19.0

682

4775

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

5.4

19.0

107

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.5

19.0

185

3375

J01DA01

ATC

[U] cefalexin; systemic

1.4

18.9

1865

15866

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

18.8

433

2706

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.0

18.8

111

381

57309

ICD-8 Finland

Other diseases of liver, Unspecified

+∞

18.8

A10BB12

ATC

glimepiride; oral

1.9

18.7

271

1454

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.6

18.6

144

198

Kela drug reimbursment

Sorafenib

12.3

18.6

WX002

NOMESCO Finland

Sedation and analgesia

1.6

18.5

599

4086

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.1

18.4

205

989

N06AA06

ATC

trimipramine; systemic

3.2

18.3

303

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

18.3

418

6178

N05AH03

ATC

olanzapine; systemic

2.2

18.3

183

841

N07BB04

ATC

naltrexone; oral

16.2

18.3

F32

ICD-10 Finland

Depressive episode

2.6

18.3

139

554

J01MA12

ATC

levofloxacin; systemic

1.6

18.2

612

4213

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

0.5

18.2

164

3065

Z50.2

ICD-10 Finland

Alcohol rehabilitation

19.4

18.2

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

12.4

18.1

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

33.1

17.9

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

15.4

17.9

L82

ICD-10 Finland

Seborrhoeic keratosis

0.5

17.8

151

2873

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

4.3

17.7

152

SPAT1262

SPAT

Handing over of treatment supplies

1.5

17.6

610

4225

J01FF01

ATC

clindamycin; systemic

1.5

17.6

813

5995

2918A

ICD-9 Finland

Alcoholic psychoses, Other specified alcoholic psychosis

9.8

17.6

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.2

17.6

180

835

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

4.8

17.4

123

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

17.4

234

3915

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

5.4

17.3

D10

ICPC

Vomiting

2.7

17.3

116

431

S00.0

ICD-10 Finland

Superficial injury of scalp

3.5

17.3

240

Y07

ICD-10 Finland

Other maltreatment

7.1

17.3

E000001

ATC

1.6

17.3

545

3692

F10.59

ICD-10 Finland

Alcohol psychosis, mixed type

21.0

17.3

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

17.2

152

658

A02BC03

ATC

lansoprazole; oral

1.4

17.0

861

6459

WW200

SPAT

0.4

17.0

1831

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

6.8

16.9

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.7

16.9

116

436

A10BH05

ATC

linagliptin; oral

2.2

16.9

168

770

P29

ICPC

Psychological sympt/compl other

2.5

16.8

136

562

K22.1

ICD-10 Finland

Ulcer of oesophagus

3.2

16.8

290

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

4.9

16.7

111

OAA67

SPAT

0.3

16.7

1066

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

15.1

16.6

N03AX14

ATC

levetiracetam; systemic

2.9

16.6

102

360

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.9

16.6

102

360

5CM18

NOMESCO Finland

7.1

16.5

L76

ICPC

Fracture: other

3.1

16.5

304

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.9

16.5

103

367

F32.1

ICD-10 Finland

Moderate depressive episode

2.5

16.5

126

506

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.3

16.3

153

682

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

16.1

282

1615

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

12.8

16.1

K08.3

ICD-10 Finland

Retained dental root

1.9

16.1

245

1338

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

16.1

130

538

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.1

16.1

288

C10AA07

ATC

rosuvastatin; oral

0.6

16.0

385

5650

ZZA00

NOMESCO Finland

Split skin graft

2.5

16.0

122

489

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

2.3

15.9

145

638

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.8

15.8

101

364

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

15.7

210

1093

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.6

15.7

113

438

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

3.6

15.7

201

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

3.7

15.7

186

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.5

15.7

106

2169

N03AF01

ATC

carbamazepine; oral, rectal

2.1

15.6

179

875

K71.1

ICD-10 Finland

Toxic liver disease with hepatic necrosis

+∞

15.6

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.8

15.6

104

385

R94.5

ICD-10 Finland

Abnormal results of liver function studies

5.5

15.5

D23

ICPC

Hepatomegaly

160.7

15.5

29100

ICD-8 Finland

Alcoholic psychosis, Delirium tremens

13.8

15.5

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

6.8

15.4

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

6.6

15.3

R83

ICPC

Respiratory infection other

0.6

15.3

214

3558

SPAT1234

SPAT

Support of social functional capacity

2.2

15.3

152

695

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

15.3

112

441

9128

FHL

Open reduction and osteosynthesis

2.7

15.2

104

393

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

15.1

296

1758

M01AH05

ATC

etoricoxib; oral

0.7

15.1

1247

14896

JN4BD

NOMESCO Finland

Extensive body CT

1.7

15.1

353

2205

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

15.1

175

861

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.5

15.1

101

2073

SPAT1307

SPAT

Psychosocial counselling and guidance

2.6

15.0

112

443

R04.0

ICD-10 Finland

Epistaxis

1.9

15.0

235

1296

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

14.9

329

2023

D64.8

ICD-10 Finland

Other specified anaemias

3.7

14.9

174

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.3

14.9

237

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

0.5

14.8

122

2349

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

14.8

311

1887

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.5

14.8

144

2636

JN4AD

NOMESCO Finland

Body CT examination

1.8

14.7

255

1459

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

21.1

14.6

M01AB01

ATC

indometacin; systemic, rectal

1.7

14.6

294

1759

P19

ICPC

Drug abuse

7.7

14.6

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

4.7

14.6

106

Y90.8

ICD-10 Finland

Blood alcohol level of 240 mg/100 ml or more

11.9

14.5

G04CA01

ATC

alfuzosin; oral

0.6

14.4

224

3628

N03AX09

ATC

lamotrigine; oral

2.4

14.4

124

529

N06AA09

ATC

amitriptyline; systemic

1.8

14.4

274

1614

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

14.4

203

1077

EBA30

NOMESCO Finland

Excision of root of tooth

2.0

14.3

189

979

SPAT1325

SPAT

Vaccination

0.7

14.3

555

7465

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

5.4

14.3

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

5.8

14.3

K20

ICD-10 Finland

Oesophagitis

3.3

14.3

212

C10AA05

ATC

atorvastatin; oral

0.7

14.2

811

10251

R10.0

ICD-10 Finland

Acute abdomen

2.6

14.2

105

415

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

14.2

183

939

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.4

14.2

121

518

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

14.0

202

1081

WVA20

NOMESCO Finland

Medicine administration

3.0

14.0

269

K07

ICPC

Swollen ankles/oedema

2.3

14.0

127

559

EBA00

NOMESCO Finland

Extraction of tooth

1.4

13.9

911

7120

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

13.9

157

763

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

13.9

328

F10.6

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Amnesic syndrome

30.1

13.9

D25

ICPC

Abdominal distension

3.7

13.8

160

RS120

NOMESCO Finland

20.1

13.8

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.1

13.7

154

748

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

13.7

314

1951

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

9.7

13.7

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

13.7

126

560

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.0

13.7

275

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.8

13.6

327

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

13.6

318

1986

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

13.6

220

1228

K75.0

ICD-10 Finland

Abscess of liver

+∞

13.5

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

13.5

143

678

KED22

NOMESCO Finland

Transurethral resection of prostate

0.4

13.5

1469

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.0

13.5

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.7

13.5

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.9

13.5

144

7803A

ICD-9 Finland

General symptoms, Convulsions

5.2

13.4

212

Kela drug reimbursment

Gout

2.7

13.4

331

T51.0

ICD-10 Finland

Toxic effect: Ethanol

9.4

13.4

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

13.3

210

1162

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

13.3

221

1245

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.7

13.2

338

D07AB08

ATC

desonide; topical

1.7

13.2

275

1664

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.9

13.2

271

F10.04

ICD-10 Finland

Alcohol-related acute intoxication with hallucinations

15.1

13.1

N03AG01

ATC

valproic acid; systemic, rectal

2.0

13.1

175

914

K29.8

ICD-10 Finland

Duodenitis

4.6

13.0

OAA80

SPAT

0.2

13.0

716

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.5

13.0

101

XKD00

NOMESCO Finland

Uroflowmetry

0.7

13.0

330

4808

D69.5

ICD-10 Finland

Secondary thrombocytopenia

8.8

13.0

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

28.5

12.9

NH1AD

NOMESCO Finland

Ankle and foot CT

3.1

12.9

224

RS221

NOMESCO Finland

3.6

12.9

160

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

12.9

251

1486

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.4

12.9

181

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

3.8

12.7

137

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

12.6

261

1574

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.4

12.5

103

430

H43.8

ICD-10 Finland

Other disorders of vitreous body

0.4

12.5

1472

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

12.5

324

2082

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

+∞

12.5

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

17.4

12.5

N05BB01

ATC

hydroxyzine; systemic

2.0

12.5

166

863

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.3

12.5

191

RS220

NOMESCO Finland

4.1

12.4

115

R40.2

ICD-10 Finland

Coma, unspecified

4.1

12.4

115

D05AX52

ATC

calcipotriol, combinations; topical

1.9

12.4

178

952

3A422

NOMESCO Finland

20.1

12.4

N30.0

ICD-10 Finland

Acute cystitis

1.7

12.4

271

1662

K76.89

ICD-10 Finland

Other specified diseases of liver

130.4

12.4

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.6

12.4

166

2792

N06AB08

ATC

fluvoxamine; oral

2.6

12.4

354

D07AA02

ATC

hydrocortisone; topical

1.6

12.3

327

2115

K29.1

ICD-10 Finland

Other acute gastritis

3.6

12.3

151

G04CB02

ATC

dutasteride; oral

0.5

12.3

1601

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

12.3

173

922

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.0

12.2

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

37.7

12.2

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.8

12.2

137

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

12.2

767

5934

I81

ICD-10 Finland

Portal vein thrombosis

7.4

12.2

XJH00

NOMESCO Finland

Transanal ultrasonography

0.5

12.1

1663

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

382

415

10.11

322.61

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

374

399

10.27

320.02

1.2

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

928

514

23.47

307.65

1.3

1.2

titre

472.0

431.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

238

74.54

307.65

1.4

1.2

g/l

47.4

31.4

0.23

151

(44816559) Phosphatidylethanol [Mass/volume] in Blood

433

473

10.19

307.65

2.7

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1152

2686

5.69

307.65

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

279

58.90

307.65

1.8

1.1

g/l

8.5

15.8

6.22

195

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

669

327

24.55

307.65

3.5

2.6

u/ml

465.3

308.2

0.19

658

317

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1627

2684

9.76

307.65

4.6

2.0

g/l

0.2

94.48

1441

2509

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

342

63.52

307.65

2.5

1.5

e6/l

2097.5

6044.3

1.37

191

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1168

2825

5.50

307.65

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

323

128

27.45

307.65

1.1

1.0

mg/l

285.3

283.1

0.11

286

117

(3033799) Differential panel - Peritoneal fluid

327

63.72

307.65

2.5

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

948

1553

7.77

307.65

1.4

2.0

g/l

1.7

1.3

3.02

846

1412

(3023183) Ammonium ion [Moles/volume] in Plasma

1248

594

30.60

307.65

6.2

1.7

umol/l

45.9

29.6

40.34

1118

500

(3007566) Smooth muscle Ab [Titer] in Serum

946

513

24.12

307.65

1.3

1.2

titre

95.8

94.5

0.02

103

(3044007) Cell count panel - Peritoneal fluid

288

58.65

307.65

2.4

1.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

514

287

20.51

307.65

1.1

g/l

1.7

1.5

6.43

447

263

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1239

3389

4.91

307.65

6.7

2.6

umol/l

27.2

8.4

27.29

1134

3000

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1528

3722

6.15

307.65

3.3

1.8

1.9

1.5

27.45

1277

3228

(3005719) IgG [Mass/volume] in Serum or Plasma

1006

2064

6.24

307.65

1.6

2.7

g/l

13.6

10.2

53.47

898

1892

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

344

144

26.13

307.65

1.2

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

377

68.40

307.65

2.5

1.7

e6/l

387.8

1230.2

2.50

269

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1230

4222

3.81

299.53

2.7

29.3

22.8

18.47

1066

3614

(3006922) Hepatitis E virus Ab [Presence] in Serum

238

132

19.15

299.40

1.1

—

(4281824)

262

180

15.54

295.91

1.3

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

233

127

19.46

295.44

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

233

127

19.46

295.44

1.1

1.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1249

4516

3.61

278.48

2.6

g/l

2.1

2.3

14.31

1121

4216

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1376

5353

3.44

272.42

4.6

3.5

mmol/l

0.7

0.8

70.09

1306

5032

(3037522) Nuclear Ab [Titer] in Serum

1069

3547

3.79

270.59

1.4

1.3

titre

324.6

490.4

3.16

226

649

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

433

686

6.98

265.51

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2018

9959

3.15

265.37

7.9

3.1

u/l

60.5

35.0

21.91

1908

9445

(3022948) Iron [Moles/volume] in Serum or Plasma

1277

4866

3.43

259.54

2.7

2.6

umol/l

13.5

12.9

1.59

1167

4539

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1180

4320

3.50

255.10

6.5

6.4

mmol/l

1.0

0.01

1111

4033

(40768441) Liver Pathology biopsy report

218

140

16.45

254.84

2.2

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

968

3195

3.71

244.47

9.3

7.8

mmol/l

10.4

10.3

0.11

932

3038

(3024561) Albumin [Mass/volume] in Serum or Plasma

2362

13453

2.95

227.78

10.9

5.0

g/l

31.4

35.3

138.41

2243

12529

(3020191) Ethanol [Moles/volume] in Serum or Plasma

253

258

10.43

222.56

2.1

1.3

promille

1.4

0.06

210

195

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

218

190

12.10

213.23

1.2

titre

98.0

134.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

218

190

12.10

213.23

1.2

titre

138.6

66.5

0.65

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

227

229

10.47

201.03

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1142

4838

2.93

184.41

1.7

1.5

g/l

5.2

2.5

102.18

902

2914

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1827

9871

2.62

182.19

5.2

2.5

u/l

63.9

58.3

1.20

1708

9187

(3033658) Prothrombin time (PT) actual/Normal

1589

8053

2.66

180.36

13.2

3.8

68.8

87.2

121.25

1522

7872

(3021879) Hepatitis B virus core Ab [Presence] in Serum

611

1813

3.82

176.54

1.3

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

551

1529

4.04

175.06

4.7

4.1

mmol/l

23.0

24.2

9.62

502

1360

(3026361) Erythrocytes [#/volume] in Blood

2822

34257

0.34

171.79

49.1

22.0

e12/l

4.0

4.6

278.27

2728

33241

(3010813) Leukocytes [#/volume] in Blood

2823

34261

0.34

171.59

49.1

22.0

e9/l

7.1

6.8

7.95

2732

33244

(3035941) MCH [Entitic mass]

2822

34252

0.34

171.37

48.9

21.9

31.5

30.5

74.69

2763

33732

(3000963) Hemoglobin [Mass/volume] in Blood

2824

34262

0.34

171.13

49.6

22.1

g/l

124.3

138.1

235.90

2764

33738

(3024731) MCV [Entitic volume]

2824

34254

0.34

170.46

48.9

21.9

93.9

91.4

89.96

2765

33734

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2533

16317

2.61

169.88

16.9

6.3

umol/l

30.7

11.7

64.99

2452

15557

(3007461) Platelets [#/volume] in Blood

2824

34239

0.34

169.21

49.1

22.0

e9/l

195.9

241.0

146.64

2741

33336

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

786

2832

3.23

167.07

4.5

2.5

u/l

36.4

38.9

0.26

698

2442

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

149

109

14.18

161.75

4.5

2.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2387

31082

0.39

161.74

4.9

4.6

mmol/l

4.3

4.5

22.14

2135

28824

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2473

31704

0.39

160.88

5.3

5.1

mmol/l

2.4

2.7

30.95

2202

29231

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2366

30858

0.40

157.99

4.9

4.6

mmol/l

1.3

1.4

14.73

2101

28437

(3042936) Bacteria identified in Isolate by Culture

1059

4701

2.73

152.54

3.1

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

798

3087

3.00

148.50

4.8

3.9

kpa

5.4

5.8

22.95

762

2993

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

399

994

4.36

145.66

2.3

1.8

—

(3000991) Gas panel - Venous blood

747

2826

3.04

144.31

12.1

9.3

—

(3002032) Base excess in Venous blood by calculation

789

3082

2.96

143.89

4.8

3.9

mmol/l

1.1

1.9

5.86

607

2479

(3022217) INR in Platelet poor plasma by Coagulation assay

1009

4590

2.62

136.40

14.7

26.2

inr

1.4

0.37

666

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

250

444

5.95

135.24

1.2

—

(3032080) INR in Blood by Coagulation assay

2150

13721

2.28

133.66

14.3

9.8

inr

1.3

0.01

563

3857

(3014111) Lactate [Moles/volume] in Serum or Plasma

750

3001

2.86

129.72

10.6

7.9

mmol/l

2.1

1.4

16.16

709

2875

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2317

29923

0.43

129.62

4.5

4.1

mmol/l

1.4

1.3

4.10

2045

27411

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1406

7604

2.34

128.84

2.8

2.2

mg/l

3.7

3.0

14.40

1242

6480

(3023368) Bacteria identified in Blood by Culture

1615

9320

2.26

126.12

6.1

4.5

—

(3003181) Sodium [Moles/volume] in Urine

252

505

5.27

119.41

1.5

1.3

mmol/l

51.5

64.1

4.14

154

408

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

20.01

116.78

3.0

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

474

1551

3.34

115.59

1.7

g/l

1.1

1.6

20.70

383

1331

(40768797) Stomach Pathology biopsy report

893

4145

2.50

113.20

1.4

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2792

33160

0.43

110.52

23.9

10.5

u/l

36.9

28.0

37.36

2730

31940

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

108

12.18

107.49

1.5

1.6

iu/ml

1956735.0

2127166.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

241

512

4.95

106.59

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

822

3832

2.46

102.10

2.4

2.5

1.8

21.41

713

3401

(3024354) Oxygen [Partial pressure] in Venous blood

614

2493

2.74

101.44

3.9

3.2

kpa

4.9

4.6

1.73

574

2406

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

117

123

9.78

100.13

2.1

2.0

umol/l

142.9

125.7

0.13

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

224

475

4.95

99.21

1.2

u/ml

325.3

278.0

1.20

147

300

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

827

3929

2.41

98.09

2.4

4.6

u/l

254.0

241.0

0.71

764

3722

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

314

893

3.74

94.46

3.2

2.5

g/l

2.8

3.7

17.36

296

852

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

241

569

4.45

93.49

1.3

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2491

30465

0.48

92.64

5.5

4.7

mmol/l

6.6

6.1

36.61

2238

27752

(46235355) HIV 1 and 2 tests - Meaningful Use set

777

3685

2.39

91.93

1.7

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1065

5843

2.14

87.98

2.1

1.8

nmol/l

1241.1

1160.5

1.68

830

4426

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1756

11550

1.96

87.16

3.6

2.8

ug/l

291.6

172.7

11.86

1614

10606

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

372

1245

3.20

86.54

2.4

ug/l

973.7

541.0

0.95

354

1182

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

483

1874

2.80

86.32

13.6

10.5

mmol/l

23.4

24.3

4.84

449

1756

(3018677) aPTT in Platelet poor plasma by Coagulation assay

981

5282

2.15

84.60

2.8

2.1

32.1

30.0

11.82

948

5135

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

878

14889

0.47

83.09

3.3

4.2

22.1

21.8

0.18

333

7315

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

353

1173

3.21

83.01

2.9

3.8

u/ml

138.4

4614.5

1.19

309

1013

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2022

14127

1.91

81.89

10.7

6.5

mmol/l

1.2

52.42

1891

12862

(3048929) Epstein Barr virus Ab [Presence] in Serum

246

676

3.82

77.52

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

798

4089

2.20

77.20

11.8

7.8

kpa

4.8

5.1

14.82

761

3912

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

208

508

4.27

77.07

1.3

1.5

u/ml

114.2

124.7

0.38

109

(3027801) Oxygen [Partial pressure] in Arterial blood

797

4088

2.20

76.87

11.8

7.8

kpa

11.4

12.1

5.33

758

3914

(3014576) Chloride [Moles/volume] in Serum or Plasma

841

4409

2.16

76.73

11.9

7.7

mmol/l

103.1

104.5

8.48

825

4304

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

239

651

3.85

76.26

6.0

5.9

iu/ml

454.2

3031.4

0.54

(3028707) Methadone [Presence] in Urine by Screen method

146

267

5.64

76.24

3.6

2.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2808

32567

0.49

75.93

42.7

17.7

mmol/l

4.0

16.35

2739

31743

(3003396) Base excess in Arterial blood by calculation

793

4082

2.19

75.68

11.9

7.8

mmol/l

-0.1

1.1

8.31

660

3186

(40761511) CBC panel - Blood by Automated count

2735

31984

0.50

75.46

32.8

14.2

—

(3044640) Blood type and Crossmatch panel - Blood

1506

9791

1.88

73.97

3.8

2.6

—

(42870588) Differential panel, method unspecified - Blood

1590

10524

1.87

73.75

6.0

5.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1263

18553

0.53

73.43

3.9

4.8

ug/l

3.3

0.00

1074

16754

(1761868) Lipid panel - Serum or Plasma

584

11113

0.44

72.50

3.4

3.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

279

871

3.38

72.42

1.5

ug/g

257.9

264.3

0.15

152

530

(3019550) Sodium [Moles/volume] in Serum or Plasma

2806

32466

0.50

72.41

42.8

17.6

mmol/l

137.6

139.7

182.05

2738

31689

(3042733) HLA Ab [Presence] in Serum

114

8.43

71.98

1.8

5.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

484

2054

2.55

71.71

9.2

8.3

mmol/l

23.3

24.8

11.18

476

2039

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

274

875

3.29

68.51

4.9

2.8

mg/l

1.9

1.6

5.72

256

799

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1218

7554

1.90

67.98

3.8

2.5

—

(3024471) HLA-A [Type]

111

8.28

67.98

1.0

—

(3024932) HLA-DR beta [Type]

109

8.33

67.61

1.0

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

600

2892

2.27

66.57

2.6

e9/l

85.5

69.1

10.45

449

2245

(3003338) MCHC [Mass/volume]

2060

25914

0.56

65.68

43.7

19.2

g/l

333.7

333.4

0.55

2026

25712

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2100

15485

1.78

65.40

11.4

7.3

mmol/l

1.2

41.26

1801

13083

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

497

2225

2.42

65.31

1.9

1.6

—

(3016502) Oxygen saturation in Arterial blood

715

3725

2.13

65.21

12.6

8.2

95.5

0.07

693

3594

(3010375) cycloSPORINE [Mass/volume] in Blood

139

7.06

63.12

36.2

23.8

ug/l

126.5

117.8

0.43

111

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2495

29639

0.55

62.62

31.7

14.1

ml/min/173m2

80.9

79.2

2.79

2187

24690

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

152

6.66

61.64

1.6

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

238

748

3.33

60.97

1.6

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

572

2811

2.22

60.12

1.7

2.7

g/l

65.5

66.3

1.37

513

2574

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

640

3325

2.11

58.23

3.1

4.4

ug/l

14.2

25.7

1.10

569

2782

(3026250) Tacrolimus [Mass/volume] in Blood

131

6.93

57.64

31.7

34.5

ug/l

7.3

0.02

121

(3009343) pH of Capillary blood

476

2208

2.32

57.32

4.8

3.6

7.4

0.35

268

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

463

2124

2.34

57.20

4.8

3.5

mmol/l

1.3

1.7

1.12

343

1553

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2488

29391

0.57

57.10

8.2

6.0

mmol/mol

41.0

40.5

1.58

2282

27217

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

270

951

2.98

56.97

2.1

2.3

59.2

90.4

44.69

256

905

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

479

2244

2.30

56.30

4.8

3.6

kpa

4.9

5.2

6.00

452

2077

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

898

5335

1.89

55.40

1.3

1.2

u/ml

3.2

2.1

0.74

166

1448

(3026782) Osmolality of Urine

1018

6309

1.83

54.83

3.2

2.8

mosm/kgh2o

479.0

572.6

35.16

897

5398

(3018418) pH of Serum or Plasma

1344

9044

1.75

54.67

5.7

4.3

7.4

1.88

283

1794

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2543

20418

1.72

53.02

10.9

3.0

u/l

204.2

52.3

120.93

2428

18975

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

632

10768

0.51

52.71

2.6

3.0

ug/l

0.7

0.8

0.45

425

7179

(3002173) Hemoglobin [Mass/volume] in Arterial blood

631

3411

2.02

51.00

13.5

8.7

g/l

111.6

122.9

29.07

614

3298

(3011288) Drugs identified in Urine by Screen method

148

381

4.00

50.98

4.0

3.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

164

454

3.73

50.97

3.7

2.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

18.01

50.73

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1106

7246

1.74

48.23

1.9

1.5

nmol/l

17.9

19.9

5.41

986

6234

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1723

12732

1.64

47.27

2.5

2.0

pmol/l

89.7

93.7

2.84

965

6997

(3016879) Cocaine [Presence] in Urine

181

563

3.32

47.05

3.8

2.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

235

854

2.87

46.73

2.2

2.6

230.3

196.5

4.68

219

815

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

863

5318

1.80

46.22

2.0

1.9

—

(3022096) Basophils/100 leukocytes in Blood

1843

13904

1.62

46.10

6.7

6.1

0.7

1.71

1740

12945

(3019069) Monocytes/100 leukocytes in Blood

1890

14371

1.62

45.59

7.1

6.4

9.6

8.9

12.94

1787

13422

(4198724)

7.28

44.90

5.0

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

115

272

4.33

44.36

1.1

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

1877

14310

1.61

44.32

6.8

6.0

2.7

2.9

2.90

1770

13306

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1403

10014

1.63

43.11

2.8

2.2

u/l

278.9

241.2

0.72

1317

9410

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

178

5.15

43.10

1.1

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

115

280

4.20

42.71

2.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

401

1954

2.17

42.29

15.0

10.7

—

(3022313) Gas panel - Capillary blood

349

1613

2.28

41.88

5.0

3.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

312

1377

2.38

41.66

5.2

3.8

mmol/l

24.2

24.8

1.88

294

1275

(3028300) Cannabinoids [Presence] in Urine

182

612

3.07

41.54

3.8

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

181

608

3.07

41.38

3.8

2.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

234

905

2.69

41.27

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

20.83

40.84

1.4

1.9

mg/l

42.8

42.6

—

(3008295) Osmolality of Serum or Plasma

116

295

4.02

40.64

1.3

mosm/kgh2o

273.1

280.2

1.84

224

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

392

1923

2.16

40.58

1.7

1.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

1900

14716

1.57

40.58

7.0

6.1

24.2

27.0

22.09

1794

13655

(3027008) Opiates [Presence] in Urine

180

611

3.04

40.41

2.6

2.0

—

(3018010) Neutrophils/100 leukocytes in Blood

1874

14500

1.57

39.98

6.7

5.9

59.1

57.8

4.98

1775

13526

(3007853) Bacteria identified in Skin by Aerobe culture

641

3758

1.85

39.80

2.1

1.8

—

(3016038) Potassium [Moles/volume] in Urine

190

4.77

39.01

1.1

mmol/l

28.3

34.8

1.81

164

(3006315) Basophils [#/volume] in Blood

1956

15361

1.56

38.50

6.6

5.8

e9/l

0.0

0.36

1694

13263

(3001604) Monocytes [#/volume] in Blood

1947

15291

1.55

38.20

6.6

5.8

e9/l

0.6

5.67

1681

13181

(3044889) 12 lead EKG panel

1873

22892

0.65

37.66

4.2

4.0

—

(3027944) Amphetamines [Presence] in Urine

172

601

2.95

36.68

4.0

2.0

—

(3013115) Eosinophils [#/volume] in Blood

1997

15875

1.54

36.34

6.9

6.0

e9/l

0.2

2.38

1741

13906

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

134

409

3.36

35.90

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

14.66

35.65

1.1

1.3

ml/s/173m2

1.2

1.0

0.20

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

8.45

35.60

1.0

1.1

—

(3036489) Thrombin time

264

1159

2.37

35.58

2.1

24.5

21.5

6.76

245

1034

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

105

274

3.91

35.52

1.2

1.1

u/l

56.3

61.5

0.37

182

(21494755) Public health laboratory ask at order entry panel

2616

0.23

35.14

1.3

1.4

—

(3024928) Oxygen saturation in Venous blood

190

722

2.72

34.65

3.0

3.2

—

(1616796) Gas panel - Central venous blood

199

777

2.65

34.40

4.3

4.0

—

(3019198) Lymphocytes [#/volume] in Blood

1966

15695

1.52

34.24

6.7

5.8

e9/l

1.7

1.9

3.03

1729

13794

(3009542) Hematocrit [Volume Fraction] of Blood

2416

27754

0.65

33.35

36.0

15.9

36.6

40.3

71.70

1543

19397

(3036481) Cortisol [Moles/volume] in Serum or Plasma

463

2587

1.90

33.03

2.0

2.3

nmol/l

376.4

368.0

0.25

424

2377

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2765

30843

0.63

32.89

34.5

15.1

mg/l

24.9

26.3

1.70

2595

24656

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

174

650

2.76

32.79

1.8

1.6

—

(3026008) Bacteria identified in Urine by Culture

1114

7923

1.57

32.68

3.5

3.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

605

3681

1.76

32.67

1.9

1.8

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

144

4.86

31.10

1.2

u/l

42.4

20.7

1.85

119

(3019060) Gas panel - Arterial blood

432

2416

1.89

30.63

6.7

4.8

—

(3010421) pH of Blood

216

931

2.40

30.29

5.5

4.7

7.4

0.35

184

784

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

395

2161

1.92

29.92

4.0

4.2

ng/l

97.1

99.6

0.18

344

1879

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2604

0.29

29.74

1.7

1.9

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

154

4.61

29.63

1.2

1.1

u/l

139.3

89.3

1.85

129

(3012501) Base excess in Blood by calculation

192

797

2.48

29.23

5.6

4.8

mmol/l

2.5

2.4

0.06

122

545

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

593

3694

1.72

29.19

1.9

1.8

—

(3013290) Carbon dioxide [Partial pressure] in Blood

192

798

2.48

29.15

5.6

4.9

kpa

4.7

5.0

5.76

183

784

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

179

723

2.55

28.87

2.2

3.9

u/ml

3456.2

915.7

0.35

167

674

(40758558) Short blood count panel - Blood

1071

7723

1.54

28.85

6.9

—

(3027315) Oxygen [Partial pressure] in Blood

192

802

2.47

28.84

5.6

4.9

kpa

8.6

8.5

0.29

183

787

(3013650) Neutrophils [#/volume] in Blood by Automated count

2135

17700

1.46

28.48

9.4

9.3

e9/l

4.3

4.2

0.34

1892

15450

(3004588) Protein electrophoresis panel - Serum or Plasma

415

2348

1.86

28.28

1.5

2.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

308

1578

2.03

28.13

3.9

2.8

1.9

1.3

9.72

308

1568

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

357

1927

1.94

28.09

1.9

1.7

—

(3012441) Differential panel - Pleural fluid

119

393

3.09

28.04

1.7

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2388

27204

0.68

27.92

4.4

4.2

mu/l

2.2

0.01

2128

24664

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

551

3407

1.72

27.77

5.2

3.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

375

2075

1.89

27.36

4.2

3.4

g/l

118.4

130.1

14.86

364

2028

(3013826) Glucose [Moles/volume] in Serum or Plasma

2251

18975

1.45

26.67

10.7

5.0

mmol/l

7.3

6.9

16.03

2162

17953

(3000093) Morphology [Interpretation] in Blood Narrative

101

316

3.26

26.06

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

124

440

2.88

25.76

1.3

1.6

g/l

0.8

0.9

0.13

331

(3030467) Casts [#/volume] in Urine by Automated count

1197

9001

1.48

25.75

4.2

3.2

e6/l

1.1

0.4

6.66

964

6842

(3002385) Erythrocyte distribution width [Ratio]

2187

25185

0.70

25.66

41.9

18.3

15.0

13.7

143.80

2149

24607

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

10.07

25.60

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

762

5218

1.57

25.41

3.4

3.0

e6/l

2.7

1.3

2.31

418

2950

(3028308) Erythrocytes [#/volume] in Pleural fluid

116

400

2.96

25.38

1.7

1.4

e6/l

47305.7

87287.1

0.81

243

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

293

1532

1.99

25.23

3.8

2.8

0.7

0.04

285

1467

(3003434) Protein [Mass/volume] in Pleural fluid

133

498

2.73

24.99

1.7

1.5

g/l

28.1

33.2

3.31

117

448

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

100

322

3.16

24.62

1.3

nmol/l

1.3

1.5

0.60

288

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1648

0.19

24.29

1.4

1.5

—

(36304419) Bacteria [Presence] in Urine

1153

8699

1.46

24.04

4.2

3.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1363

16934

0.70

23.83

2.8

2.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1779

14561

1.41

23.58

6.0

4.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

161

684

2.41

23.32

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

161

684

2.41

23.32

1.4

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

163

701

2.38

22.98

1.2

1.6

nmol/l

0.9

0.8

0.49

124

580

(3052851) Hemolysis interference index of Serum or Plasma

194

902

2.21

22.78

5.4

3.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

119

443

2.74

22.63

1.7

1.4

e6/l

15996.7

2059.4

0.83

314

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

244

1244

2.03

22.53

3.6

3.0

u/ml

0.3

5.15

113

702

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

7.23

22.46

1.0

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

935

6854

1.48

22.28

3.2

2.7

e6/l

6.8

3.9

6.35

834

6032

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

173

781

2.27

21.82

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

279

1510

1.91

21.68

2.4

1.9

ug/l

2.6

0.02

253

1344

(3002582) Erythrocytes [#/volume] in Urine

1269

9905

1.42

21.48

4.3

3.3

e6/l

58.3

91.5

1.30

1038

7734

(3017315) Amylase [Enzymatic activity/volume] in Urine

160

3.92

21.40

1.5

1.2

u/l

324.8

429.7

0.33

149

(3028271) Lactate [Moles/volume] in Capillary blood

135

562

2.45

20.47

2.9

2.0

mmol/l

2.0

1.7

2.09

135

549

(36660697) Celiac disease serology panel - Serum

331

1924

1.79

20.46

1.2

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

41.88

20.44

2.0

1.0

0.3

0.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

199

977

2.09

20.35

1.4

2.3

g/l

34.6

37.8

7.47

162

851

(3045788) Cell count panel - Pleural fluid

345

2.86

20.13

1.7

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

195

955

2.10

20.08

1.4

2.4

g/l

0.0

0.10

166

877

(3028626) Oxygen [Partial pressure] in Capillary blood

166

764

2.23

20.00

3.6

2.9

kpa

7.9

0.05

156

696

(3022493) Free Hemoglobin [Mass/volume] in Plasma

129

4.15

19.81

1.3

7.9

mg/l

56.9

65.1

0.31

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

184

892

2.12

19.46

1.4

2.4

g/l

0.0

0.50

155

816

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

181

879

2.11

19.06

1.4

2.4

g/l

0.0

0.00

155

815

(40767503) Oxygen content in Capillary blood by calculation

161

749

2.20

18.91

4.0

2.6

15.1

16.3

3.01

383

(3034274) Bile acid [Moles/volume] in Serum --fasting

100

4.54

18.89

1.8

1.5

umol/l

40.7

12.7

2.18

(3009445) Proteinase 3 Ab [Units/volume] in Serum

253

1388

1.88

18.84

1.2

1.5

u/ml

4.3

18.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

765

5550

1.47

18.79

3.4

2.8

e6/l

1.6

0.9

3.06

423

3260

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

118

481

2.50

18.74

6.3

7.1

mg/l

12.5

11.7

1.18

106

446

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

206

1056

2.00

18.74

1.4

3.6

mg/l

50.9

60.4

0.32

153

846

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.76

18.67

1.1

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.66

18.66

1.1

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

205

1057

1.99

18.35

1.4

3.6

mg/l

88.3

61.9

0.59

152

845

(40768806) Pleura Pathology biopsy report

103

398

2.63

18.27

1.7

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

208

1086

1.97

17.96

1.4

2.6

g/l

0.3

1.1

5.53

168

940

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

199

1032

1.98

17.53

1.4

3.6

ratio

2.0

2.4

0.15

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

137

3.83

17.49

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

137

3.83

17.49

1.4

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

284

1653

1.78

17.44

4.4

3.6

mmol/l

24.3

25.1

3.10

270

1604

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2689

24191

1.37

17.06

18.8

7.6

u/l

114.5

77.7

112.48

2606

22834

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

265

1533

1.78

16.61

5.2

4.1

50.3

49.0

0.33

260

1513

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

220

1202

1.88

16.60

1.3

2.5

g/l

3.2

3.0

0.89

171

945

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

10.63

16.43

1.2

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

219

1204

1.87

16.21

1.4

2.5

g/l

12.7

10.1

8.06

176

1025

(3036782) Glucose [Moles/volume] in Pleural fluid

352

2.62

16.15

1.4

mmol/l

6.6

6.2

0.55

323

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

169

3.41

16.14

1.7

1.5

u/l

5.4

7.3

0.33

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1376

11272

1.34

16.11

2.8

2.2

nmol/l

66.6

76.9

26.99

1238

10078

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

341

2.65

16.09

1.3

u/l

1237.7

380.9

0.74

323

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

5.28

16.06

9.5

2.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

332

2.63

15.34

2.7

—

(3018095) Leukocytes [#/volume] in Urine

1354

11148

1.33

15.04

4.8

3.8

e6/l

104.9

93.0

0.14

1051

8241

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1293

1.80

14.99

1.3

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1293

1.80

14.99

1.3

2.4

g/l

7.1

7.3

1.04

171

964

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

228

1302

1.80

14.93

1.5

1.9

u/l

48.4

38.3

6.05

209

1129

(3008116) Ketones [Moles/volume] in Urine by Test strip

5.03

14.77

1.8

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

226

1293

1.79

14.71

1.3

2.4

g/l

4.7

3.8

8.22

168

926

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

195

3.11

14.68

1.3

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1848

0.40

14.60

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

272

2.75

14.54

1.3

u/l

19.3

14.2

0.34

254

(3051651) Icteric interference index of Serum or Plasma

181

3.18

14.50

3.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

192

3.11

14.41

1.3

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

856

6627

1.37

14.09

1.8

1.7

pmol/l

561.1

27191016.5

4.45

678

5535

(3020891) Body temperature

243

1442

1.73

13.95

7.9

5.0

—

(3021901) Oxygen saturation in Capillary blood

132

644

2.09

13.81

3.8

2.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1916

21649

0.77

13.79

3.5

pmol/l

14.6

14.9

4.21

1689

19552

(3018405) Lactate [Moles/volume] in Arterial blood

222

1290

1.77

13.72

6.7

4.3

mmol/l

2.0

1.4

5.63

216

1272

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

157

3.28

13.66

1.6

1.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

170

917

1.89

13.38

4.1

3.1

mmol/l

23.2

24.8

3.14

150

793

(3039443) Prostate specific Ag panel - Serum or Plasma

1140

0.28

13.30

1.5

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

156

821

1.94

13.22

1.4

3.7

—

(3029075) Extractable nuclear Ab panel - Serum

4.15

13.20

1.0

—

(3000494) Fungus identified in Specimen by Culture

522

3757

1.45

12.97

1.7

1.5

—

(3037756) Immunofixation for Serum or Plasma

142

731

1.98

12.84

1.2

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

1285

10683

1.30

12.79

3.7

3.2

mmol/l

7.0

8.2

17.33

1065

8977

(3019225) pH of Specimen

444

3105

1.49

12.78

5.7

4.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

109

513

2.16

12.54

1.1

iu/ml

86.7

88.4

0.01

102

(3051611) Lipemic interference index of Serum or Plasma

291

2.54

12.27

3.7

3.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

340

2269

1.55

12.20

11.6

7.3

mmol/l

23.3

24.6

5.75

322

2132

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

815

6426

1.34

11.63

4.6

3.9

ng/l

272.6

657.5

1.66

698

5306

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

153

3.10

11.54

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

153

3.10

11.54

1.4

1.5

—

(3035880) pH of Pleural fluid

213

2.75

11.49

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

661

8469

0.74

11.36

1.8

1.7

mmol/l

1.5

1.4

1.81

561

7043

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

223

1371

1.67

11.26

2.2

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

178

2.89

11.11

1.3

nmol/l

1.1

0.14

134

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

232

1448

1.64

11.05

7.4

5.1

2.1

1.7

4.26

216

1364

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

206

1248

1.69

11.00

2.0

1.8

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

126

3.20

10.39

1.6

1.4

3.0

2.3

0.18

107

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

142

3.05

10.33

2.4

2.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

150

2.96

10.02

1.7

1.4

55.6

65.0

0.92

121

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

810

6540

1.30

9.55

1.8

mg/l

2.4

1.3

7.77

680

5105

(4035726)

379

2718

1.44

9.51

1.5

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.69

9.42

1.3

1.5

ug/l

13.9

8.3

3.33

(3025941) Bacteria identified in Stool by Culture

233

1516

1.57

9.37

1.4

1.3

—

(1002224) Polysomnography panel

1305

0.44

9.18

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

969

11501

0.79

8.94

4.5

3.6

—

(44786800) Granulocytes/100 leukocytes in Body fluid

4.33

8.86

1.6

1.4

28.4

27.0

0.06

(3037121) Protein [Mass/volume] in Urine

179

1110

1.64

8.79

3.1

3.3

g/l

0.4

0.3

1.11

505

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

122

2093

0.57

8.67

1.7

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

194

1233

1.60

8.63

2.2

2.6

—

(3021589) Normoblasts [#/volume] in Blood

1547

13607

1.23

8.58

15.7

10.0

e9/l

0.0

0.42

1248

11220

(3014271) Vancomycin [Susceptibility]

164

2.70

8.56

3.3

2.8

—

(3047181) Lactate [Moles/volume] in Blood

177

1103

1.63

8.54

8.2

6.1

mmol/l

2.2

1.3

4.94

148

983

(3031040) Bacteria [#/volume] in Urine by Automated count

2147

19534

1.22

8.52

5.4

4.2

e6/l

2755.6

1304.1

0.27

312

(3007930) Methemoglobin/Hemoglobin.total in Blood

218

1431

1.55

8.46

7.5

5.2

0.9

0.41

205

1351

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

356

2580

1.42

8.43

5.9

4.4

mmol/l

1.2

7.17

333

2295

(3042517) Benzodiazepines panel - Urine

7.52

8.41

1.5

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

359

2.11

8.39

2.7

4.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

145

2.78

8.21

1.1

u/l

112.2

101.1

0.18

114

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

139

822

1.72

8.19

1.4

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

161

991

1.65

8.17

1.8

1.6

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

146

2.76

8.11

1.1

u/l

51.4

33.7

0.38

109

(3020491) Glucose [Moles/volume] in Blood

219

2.39

7.91

2.7

2.1

mmol/l

8.7

7.0

1.80

146

(3024891) Influenza virus A+B Ag [Presence] in Specimen

127

740

1.74

7.90

1.3

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

213

2.41

7.90

1.2

mmol/l

13.0

11.5

0.83

(3001019) Free T4 and TSH panel - Serum or Plasma

1113

0.45

7.71

1.5

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.20

7.65

1.1

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

367

2.04

7.58

1.4

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

543

1.84

7.55

1.2

1.3

miu/ml

236.6

198.9

0.24

206

(40759836) Histone Ab [Presence] in Serum by Immunoblot

188

2.46

7.48

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

188

2.46

7.48

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

188

2.46

7.48

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

369

2.03

7.47

1.4

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

172

1105

1.58

7.36

7.6

4.6

mmol/l

3.9

0.63

161

1036

(3015377) Calcium [Moles/volume] in Serum or Plasma

1160

10025

1.22

7.35

3.4

3.5

mmol/l

2.3

8.16

983

8762

(3017446) Testosterone [Moles/volume] in Serum or Plasma

269

3731

0.70

7.27

2.0

2.2

nmol/l

13.5

13.1

0.33

222

3302

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

373

2.00

7.26

1.4

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

191

2.43

7.24

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

191

2.43

7.24

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

191

2.43

7.24

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

127

759

1.70

7.24

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

127

764

1.68

7.08

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

134

2.70

7.08

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

297

2.11

6.99

1.2

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

131

799

1.66

6.94

1.4

g/l

0.2

1.98

122

760

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

673

5510

1.27

6.90

3.6

3.3

mmol/l

2.5

2.4

8.90

537

4831

(3017181) Myelocytes/100 leukocytes in Blood

360

2704

1.37

6.89

4.5

4.2

0.9

1.0

0.17

140

845

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

110

641

1.74

6.89

1.4

1.5

—

(40768446) Kidney Pathology biopsy report

125

2.74

6.85

1.4

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

127

772

1.67

6.82

1.2

—

(4094501)

1019

0.46

6.77

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1243

10894

1.21

6.70

4.4

4.0

mg/mmol

15.6

9.4

3.51

818

7214

(3025468) Yersinia sp identified in Specimen by Organism specific culture

364

1.97

6.68

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

364

1.97

6.68

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

365

1.96

6.63

1.4

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.34

6.49

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

382

1.93

6.48

94.8

6.5

mmol/l

7.6

7.5

0.11

320

(3002179) Metamyelocytes/100 leukocytes in Blood

325

2436

1.36

6.31

4.1

4.0

0.6

0.10

103

607

(3006184) Hemoglobin [Mass/volume] in Capillary blood

122

750

1.65

6.30

3.2

2.2

g/l

120.7

131.2

4.86

534

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

132

828

1.62

6.29

1.4

g/l

1.1

1.2

1.79

123

785

(3032057) Clostridioides difficile [Presence] in Stool

3.35

6.27

1.7

2.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

226

3147

0.70

6.25

1.5

—

(3012516) Albumin [Mass/volume] in Urine

1182

10367

1.20

6.23

3.6

3.3

mg/l

348.5

370.8

0.07

806

6888

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.67

6.19

1.4

ug/l

0.3

0.61

(3014148) Varicella zoster virus Ab [Titer] in Serum

279

2.06

6.12

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

286

2.04

6.10

1.2

1.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

12.53

6.08

1.0

1.3

mmol/l

—

(3011648) Oxygen content in Venous blood

267

2.08

6.04

2.3

2.1

9.5

11.4

2.32

267

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

171

2.35

5.97

1.1

—

(3018572) Chloride [Moles/volume] in Blood

127

801

1.61

5.94

9.8

6.8

mmol/l

103.6

105.3

2.05

114

725

(3039000) Anion gap in Blood

127

801

1.61

5.94

9.8

6.8

mmol/l

13.6

11.4

5.29

114

725

(3045716) Anion gap in Serum or Plasma

172

2.34

5.90

3.4

2.4

mmol/l

8.5

9.7

1.01

133

(3042631) Mycobacterium sp identified in Specimen

497

1.77

5.89

2.1

2.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1423

12747

1.18

5.82

5.3

3.7

ng/l

40.3

56.9

1.72

1181

9353

(3026493) Urate [Moles/volume] in Serum or Plasma

1056

9226

1.20

5.71

3.6

2.8

umol/l

394.6

4742.9

20.54

901

8014

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1110

9743

1.20

5.71

3.1

ng/l

1891.4

1522.8

1.39

973

8369

(3044927) Protein electrophoresis panel - Urine

336

1.89

5.35

1.2

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.10

5.33

1.6

1.5

11.7

5.8

0.59

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

11.27

5.29

1.0

—

(3025159) Blasts/100 leukocytes in Blood

312

2390

1.33

5.28

4.6

4.2

0.0

0.3

1.04

113

650

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

320

1.89

5.11

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

574

1.65

5.06

2.9

3.6

1.4

1.5

0.15

438

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

166

2.24

5.00

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

253

1.99

4.97

1.4

1.3

iu/ml

35.6

27.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

328

2556

1.31

4.93

4.6

4.2

0.1

0.48

126

787

(3027456) Digoxin [Moles/volume] in Serum or Plasma

581

1.63

4.84

2.7

3.0

nmol/l

0.8

0.09

440

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

915

0.53

4.81

1.3

1.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.28

4.74

1.0

1.5

—

(40768800) Prostate Pathology biopsy report

1176

0.59

4.73

1.1

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

283

3637

0.76

4.67

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

109

2.49

4.62

1.3

ug/l

3.3

120.6

1.35

(21494890) Protein electrophoresis panel - 24 hour Urine

369

1.77

4.58

1.2

2.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

360

2874

1.28

4.51

2.7

2.9

ng/l

250.8

207.6

1.05

334

2612

(4146454)

381

1.75

4.41

2.8

2.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

163

2.16

4.36

1.1

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

219

1.97

4.25

1.3

u/l

25.1

27.0

0.11

175

(3027135) IgG subclass 1 [Mass/volume] in Serum

290

1.84

4.24

1.2

1.3

g/l

7.8

6.5

1.24

202

(3009871) Measles virus Ab [Titer] in Serum

2.56

4.21

1.9

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

611

1.57

4.20

1.2

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

690

7940

0.84

4.10

4.1

3.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

181

2.05

4.09

3.4

2.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

204

1.97

3.96

1.9

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

290

1.80

3.94

1.2

1.3

g/l

0.4

0.33

201

(3028192) IgG subclass 2 [Mass/volume] in Serum

290

1.80

3.94

1.2

1.3

g/l

3.2

2.9

0.35

201

(3028717) Thiamine [Mass/volume] in Blood

3.43

3.90

1.3

1.2

—

(4062490)

292

1.79

3.86

1.2

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

107

2.35

3.82

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

137

972

1.42

3.80

2.2

2.3

ug/min

301.6

118.5

1.68

603

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

643

1.52

3.79

1.1

u/ml

9.2

8.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

556

1.56

3.76

1.1

1.2

u/ml

2.4

8.0

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

141

2.14

3.70

15.1

12.7

mmol/l

0.6

0.29

134

(3017354) Segmented neutrophils/100 leukocytes in Blood

357

1.69

3.66

3.2

3.7

62.8

56.7

1.28

220

(3000012) Reticulocyte production index

171

2.00

3.53

2.4

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

105

2.29

3.52

1.1

miu/ml

1706.0

1573.8

0.28

105

(3004616) Nuclear Ab [Presence] in Serum

332

1.70

3.48

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.54

3.46

1.1

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

290

1.73

3.37

1.5

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.84

3.35

10.0

12.6

mmol/l

4.7

5.7

1.04

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

524

1.54

3.34

4.7

4.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.25

3.34

2.2

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.25

3.34

2.1

—

(3019977) pH of Arterial blood

197

1.89

3.29

4.4

2.6

7.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.39

3.22

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

100

694

1.45

3.18

1.2

mmol/l

4.2

3.9

1.66

648

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

186

1.89

3.14

1.9

2.0

ug/min

65.7

266.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.29

3.09

1.2

1.3

nmol/l

252.2

129.4

0.55

(40761536) Microorganisms panel - Urine sediment

309

2539

1.24

3.09

5.1

3.9

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

110

784

1.41

3.04

1.2

1.3

mg/l

548.3

560.1

0.06

104

739

(3015171) Extractable nuclear Ab [Units/volume] in Serum

134

990

1.37

3.00

1.2

u/ml

0.4

0.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

114

820

1.40

3.00

1.4

1.8

—

(3002619) Bacteria identified in Specimen by Culture

2.75

2.98

1.6

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

2.16

2.96

4.2

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

2.16

2.96

4.2

2.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.24

2.96

1.1

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

460

0.50

2.94

1.7

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

103

731

1.42

2.93

1.2

u/ml

41.5

37.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

374

4411

0.83

2.91

1.3

1.2

u/ml

11.4

13.8

0.25

104

1704

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.22

2.89

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

571

6495

0.86

2.88

4.4

3.8

kg/l

1.0

3.59

942

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

251

1.72

2.88

2.1

2.2

u/l

319.1

1804.4

0.69

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

127

938

1.37

2.87

1.3

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

117

855

1.38

2.83

1.4

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

330

2759

1.21

2.81

3.7

2.7

ml/min/173m2

56.9

65.3

2.47

139

1074

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

130

2.01

2.80

2.5

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

401

4679

0.84

2.77

1.3

iu/ml

54.1

36.7

0.64

122

1450

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.23

2.77

1.1

2.4

mmol/l

0.7

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

8.34

2.75

1.0

u/field

1.0

1.2

—

(40768804) Tissue Pathology biopsy report

1104

11981

0.89

2.73

2.2

2.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

367

0.46

2.72

1.5

1.4

pmol/l

69.4

147.3

—

110

(3009261) Glucose [Presence] in Urine by Test strip

1388

14867

0.90

2.71

4.0

3.5

estimate

0.0

1.74

306

2652

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1154

0.70

2.70

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.22

2.67

1.3

1.5

—

(3023410) Appearance of Cerebral spinal fluid

312

1.61

2.64

1.3

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

680

1.41

2.62

1.3

1.4

e6/l

361.9

1018.9

0.97

554

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

680

1.41

2.62

1.2

1.4

e6/l

16.7

22.4

0.18

524

(3026389) Candida sp identified in Specimen by Organism specific culture

321

1.60

2.60

1.4

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

631

1.42

2.59

1.4

1.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

401

1.53

2.58

2.3

2.1

mg/l

18.8

23.8

0.46

(3017509) Phencyclidine [Presence] in Urine

3.61

2.57

2.0

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

1374

14693

0.90

2.57

5.1

4.6

estimate

0.0

0.00

328

2811

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.39

2.46

1.1

1.3

mmol/l

0.4

0.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

555

1.43

2.43

1.2

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.09

2.42

1.5

1.4

umol/l

1.4

1.9

1.28

(3027974) Hepatitis B virus e Ag [Presence] in Serum

5.01

2.40

1.2

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

624

1.40

2.40

3.7

3.6

60.0

58.3

0.56

624

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

227

1.68

2.39

1.2

1.6

u/ml

25.6

21.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

110

1455

0.75

2.35

2.3

3.4

pmol/l

4.1

4.5

2.84

1287

(3004716) Salmonella sp identified in Stool by Organism specific culture

147

1148

1.29

2.32

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

365

1.51

2.27

2.8

3.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

692

1.37

2.24

1.2

u/ml

3.3

5.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

401

1.48

2.19

1.4

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

130

1659

0.78

2.16

1.2

1.3

u/ml

754.5

254.1

1.20

124

1523

(3009466) Valproate [Moles/volume] in Serum or Plasma

477

1.43

2.15

4.5

5.1

umol/l

356.9

356.2

0.01

415

(3025315) Body weight

3.20

2.09

4.3

3.0

—

(3004451) EKG impression Narrative

176

1.71

2.05

1.1

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

169

1.72

2.03

1.1

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.00

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

377

0.55

2.00

1.1

u/ml

1.3

2.0

—

161

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

241

1.58

1.95

1.4

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

505

1.39

1.93

1.4

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

372

1.46

1.91

1.2

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

550

1.37

1.88

1.4

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

1391

14696

0.92

1.87

3.9

3.4

estimate

0.0

0.50

321

2737

(3021788) Differential panel - Synovial fluid

611

1.35

1.86

1.5

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.65

1.86

1.0

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

648

0.68

1.85

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.94

1.84

2.9

6.0

32.8

75.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.21

1.84

1.3

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

167

1.68

1.83

1.1

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

326

0.55

1.79

1.1

u/ml

0.3

1.2

—

134

(3035947) Staphylolysin Ab [Units/volume] in Serum

169

1.66

1.76

1.3

1.1

iu/ml

3.3

4.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

154

0.39

1.75

6.0

6.8

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.03

1.74

1.1

1.2

mmol/l

1.2

1.7

—

(3004775) Volume in Urine collected for unspecified duration

322

1.47

1.73

1.9

2.2

884.3

626.0

1.81

212

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

209

1.58

1.73

1.5

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

335

0.57

1.73

1.1

u/ml

1.2

4.5

—

155

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.85

1.71

1.0

1.2

nmol/l

212.8

258.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

500

1.37

1.70

1.4

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

218

1.56

1.70

1.1

—

104.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

571

0.68

1.63

1.7

1.8

iu/l

3.6

4.6

1.28

186

(3038177) Helicobacter pylori Ab [Presence] in Serum

445

1.38

1.62

1.5

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

264

0.53

1.62

1.1

1.0

u/ml

10.2

2.3

—

105

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.57

1.61

1.2

1.0

—

(3028433) Virus identified in Specimen by Culture

113

1.77

1.60

1.2

—

(3011985) Renin [Units/volume] in Plasma

405

1.39

1.57

1.2

1.4

mu/l

111.6

57.3

0.38

367

(3017569) Oxygen content in Arterial blood

175

1.60

1.57

3.8

2.4

—

(3017704) Immunofixation for Urine

191

1.58

1.56

1.1

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

223

1.53

1.56

1.1

—

60.0

—

(3022145) Colonoscopy Study observation

395

3531

1.13

1.55

1.4

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

156

0.45

1.54

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

614

1.31

1.54

1.4

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

383

0.62

1.52

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

667

0.72

1.52

1.4

1.3

—

(3016750) Collection duration of Urine

233

1.51

1.9

2.1

min

484.5

487.7

0.05

170

(3003740) Influenza virus B Ag [Presence] in Specimen

382

0.63

1.50

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.86

1.50

1.5

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

234

1.50

1.49

1.5

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

325

1.42

1.49

1.2

1.4

—

(3044941) Cell count panel - Synovial fluid

522

1.33

1.48

1.5

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

361

3220

1.13

1.47

2.6

2.4

ug/l

6.8

8.6

1.27

313

2893

(3043410) Blood group antigens tested for on Red Blood Cells

1.81

1.47

2.4

2.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

102

814

1.26

1.47

1.6

e6/l

19986.7

15996.5

0.33

579

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

367

0.62

1.46

1.1

—

9.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

708

0.73

1.46

4.0

3.4

mg/l

38.6

28.1

1.05

437

(3023430) Cat dander IgE Ab [Units/volume] in Serum

241

0.54

1.45

1.1

1.0

u/ml

16.3

3.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.73

1.43

1.0

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

346

0.63

1.34

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

120

1.67

1.34

1.2

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

113

1.68

1.31

2.2

2.3

nmol/l

152.0

142.4

0.10

(3000330) Specific gravity of Urine by Test strip

131

1564

0.83

1.29

3.3

3.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.94

1.27

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

210

1.48

1.27

1.5

1.6

—

(40768443) Skin Pathology biopsy report

160

1361

1.18

1.27

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

118

1420

0.83

1.27

1.1

1.2

iu/ml

107.0

139.2

0.35

499

(3049717) Cytology report of Urine Cyto stain

129

1537

0.83

1.25

2.6

2.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2142

20801

1.07

1.23

5.0

4.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

349

0.66

1.21

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

357

1.35

1.20

1.5

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

148

1.56

1.20

3.2

2.2

umol/l

63.4

57.1

0.33

124

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

383

0.68

1.19

1.3

1.2

mmol/l

9.7

7.5

1.67

285

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

516

1.28

1.17

2.1

2.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.71

1.17

1.3

—

(3001729) Color of Synovial fluid

0.00

1.16

0.0

1.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

1.16

0.0

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

1.16

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.50

1.15

1.2

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

1.14

0.0

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

1.14

0.0

5.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.34

1.12

1.0

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.00

1.12

1.1

1.3

—

577.7

—

(40768795) Lymph node Pathology biopsy report

292

0.65

1.08

1.3

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

496

1.27

1.08

1.4

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

378

4129

0.91

1.06

14.1

7.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.12

1.05

1.0

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.96

1.03

1.7

2.0

ng/l

87.0

195.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

332

1.33

1.03

1.4

e6/l

312863.0

118807.0

0.65

235

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.74

1.02

1.2

1.1

68.0

83.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.92

1.02

1.0

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

412

1.29

1.01

2.7

2.3

mmol/l

104.9

105.7

0.50

405

(3041354) Potassium [Moles/volume] in Venous blood

412

1.29

1.01

2.7

2.3

mmol/l

4.0

4.1

0.42

405

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

395

1.30

1.00

1.5

1.3

nmol/l

0.7

0.6

0.48

374

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

205

1.42

1.00

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

107

1.59

0.99

1.6

1.2

g/l

39.4

39.9

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

213

0.61

0.99

3.3

5.5

u/ml

76.6

40.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.18

0.98

1.0

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.97

0.0

1.5

—

0.5

—

(3006270) Folate [Moles/volume] in Blood

267

1.35

0.96

1.1

1.2

nmol/l

297.4

348.8

0.99

233

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.95

0.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

141

1.49

0.94

1.3

2.6

—

(4010399)

253

2281

1.12

0.94

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

117

0.51

0.94

1.0

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

382

1.29

0.93

1.2

1.4

pmol/l

449.0

269.1

1.27

295

(3029937) Albumin [Presence] in Urine by Test strip

769

8111

0.94

0.93

4.6

3.9

estimate

0.0

0.04

294

2615

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.22

0.93

2.0

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.22

0.93

1.5

3.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

442

0.74

0.92

1.4

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.14

0.91

1.2

3.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

184

1.42

0.91

3.7

3.5

—

(3022621) pH of Urine by Test strip

175

1973

0.88

0.89

2.9

2.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.07

0.89

1.5

2.7

u/field

0.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

394

1.27

0.89

1.5

1.3

nmol/l

0.1

0.3

1.12

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

105

0.48

0.88

1.0

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

277

0.68

0.88

1.3

1.8

mg/l

6.7

4.6

0.61

268

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.61

0.87

1.3

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.86

0.87

1.1

1.2

—

(4212803)

2.00

0.87

1.0

1.1

—

(21494434) Karyotype in Bone marrow

334

1.29

0.86

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

195

1.39

0.86

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.82

0.85

1.1

2.2

umol/l

18.0

17.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

424

1.25

0.84

2.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

752

1.19

0.84

1.3

u/l

10.8

7.6

1.33

610

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.78

0.84

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.78

0.84

2.6

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.78

0.84

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

162

1.42

0.84

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

141

0.57

0.82

1.1

1.6

ug/l

11.6

9.1

—

124

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

346

1.27

0.81

1.5

1.3

nmol/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.79

0.0

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

139

1.44

0.79

1.3

2.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

139

1.44

0.79

1.3

2.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.67

0.78

1.4

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.78

0.0

4.9

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

208

1.35

0.77

1.1

mg/l

281.3

312.4

0.59

183

(3048879) Bone marrow aspiration report

1.52

0.75

1.1

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

149

1.41

0.75

1.0

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.60

0.74

1.2

1.3

70.5

82.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

161

1794

0.89

0.72

1.1

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.62

0.71

1.2

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.75

0.71

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

217

0.69

0.70

1.3

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.51

0.69

1.1

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

319

1.26

0.69

1.3

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

319

1.26

0.69

1.3

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

319

1.26

0.69

1.3

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

135

1.41

0.69

3.5

2.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.85

0.68

2.8

3.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.85

0.68

1.0

—

(40757373) Influenza virus identified in Isolate

1.60

0.68

1.4

1.5

—

(4027681)

161

1.37

0.68

1.4

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

196

1.33

0.67

6.0

2.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.79

0.66

4.0

8.6

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

146

1.37

0.63

2.1

2.5

u/ml

1132.6

1147.1

0.01

146

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

172

1562

1.11

0.63

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

610

0.83

0.62

1.2

1.4

iu/l

31.7

28.7

0.26

514

(4034850)

1016

0.87

0.61

15.9

9.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

182

1.32

0.61

1.3

2.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

182

1.32

0.61

1.2

2.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

182

1.32

0.61

1.3

2.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

182

1.32

0.61

1.3

2.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2219

22566

0.96

0.61

4.9

3.9

mm/h

21.7

12.1

81.00

2017

20876

(3025130) Human papilloma virus identified in Specimen

138

0.65

0.60

1.2

1.9

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

218

1.29

0.60

1.3

1.1

mg/l

43.9

45.5

0.10

183

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.59

0.0

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

0.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.53

0.59

1.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

818

1.14

0.59

1.6

1.9

mg/l

13.7

11.6

0.95

760

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

443

0.81

0.58

1.0

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

2.1

—

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

156

1419

1.10

0.57

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

1.51

0.56

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

485

1.18

0.56

1.1

—

(3020650) Glucose [Presence] in Urine

0.57

0.56

1.6

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

320

1.22

0.55

1.1

—

22.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.62

0.55

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

123

0.65

0.54

1.4

1.2

—

(40765096) Chromosome analysis panel by Banding

124

0.64

0.54

1.1

—

(3014891) Appearance of Pleural fluid

1.50

0.54

3.1

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

267

1.24

0.53

1.0

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.62

0.52

1.3

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.62

0.52

1.0

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

398

1.18

0.50

2.9

2.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.46

0.50

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

688

6629

1.05

0.50

5.5

4.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.43

0.49

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

323

0.80

0.48

1.1

u/ml

2.7

—

142

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

354

1.19

0.48

1.3

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

588

1.14

0.47

1.1

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

285

3021

0.94

0.46

2.1

2.4

ug/g

214.9

160.5

1.25

227

2429

(44790048)

393

1.17

0.45

1.2

1.5

—

(44790047)

393

1.17

0.45

1.2

1.5

—

(44790049)

393

1.17

0.45

1.2

1.5

—

(44806118)

393

1.17

0.45

1.2

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.60

0.45

1.4

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

283

1.20

0.45

1.0

—

(3047189) Immunofixation for 24 hour Urine

165

1.27

0.45

1.1

1.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

376

1.17

0.44

1.3

1.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

121

1.32

0.44

1.3

1.8

nmol/l

3.4

8.8

0.76

105

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

220

1.23

0.43

1.3

1.2

—

(3045414) Leukocytes [Presence] in Urine

125

1363

0.91

0.43

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

808

0.89

0.43

1.4

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

417

3988

1.05

0.43

4.4

4.6

31.4

31.6

0.11

317

2709

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.64

0.42

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.64

0.42

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.64

0.42

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.64

0.42

1.2

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.41

0.0

1.4

—

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.40

0.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

123

1.30

0.40

2.9

2.8

umol/l

34.9

29.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.47

0.40

1.0

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.33

0.40

1.9

mmol/l

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

227

0.79

0.40

2.5

2.2

15.3

15.5

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.40

0.0

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

616

1.12

0.39

1.4

1.6

—

(4015189)

1.33

0.37

1.3

1.9

—

(3013512) EKG study

944

9669

0.97

0.37

5.0

4.0

—

(3014051) Protein [Presence] in Urine by Test strip

681

0.89

0.35

2.1

2.2

—

(3005033) Fetal Nuchal fold Thickness US

0.62

0.35

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.62

0.35

1.2

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

108

1.30

0.35

1.1

1.4

—

(3017732) Neutrophils [#/volume] in Blood

226

2141

1.06

0.35

2.9

3.3

e9/l

4.1

4.2

0.31

170

1644

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

123

0.73

0.35

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

126

1.27

0.35

1.3

1.1

iu/ml

349.3

196.4

0.68

126

(3037692) Legionella sp identified in Specimen by Organism specific culture

126

1.27

0.35

1.2

1.4

—

(3008898) HLA-B27 [Presence]

790

0.91

0.32

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

176

0.79

0.32

1.2

1.7

—

(44813793)

165

0.79

0.32

1.1

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

455

1.12

0.32

1.4

1.2

u/ml

3.4

4.6

0.55

202

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

174

1.21

0.31

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

747

0.91

0.31

1.3

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

131

0.76

0.30

1.7

2.3

ug/l

12.8

83.3

—

118

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

153

0.78

0.30

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

708

6906

1.03

0.30

3.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

218

0.82

0.30

2.5

2.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

410

1.12

0.29

1.5

1.6

73.2

61.2

1.17

265

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

185

0.81

0.29

1.4

1.3

u/ml

3.9

0.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

817

0.92

0.29

3.5

3.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.28

0.28

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

447

0.89

0.26

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

338

1.13

0.26

3.9

3.1

mg/l

67.8

72.2

0.05

266

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.26

0.26

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

127

0.79

0.25

1.9

2.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

105

1.24

0.24

1.1

u/ml

9.1

4.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.17

0.24

2.1

2.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.25

0.22

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

0.74

0.22

2.4

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

107

1.22

0.21

6.8

7.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

2.7

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

2.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

1.4

—

8.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.4

—

3.9

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.4

—

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.9

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.4

—

3.4

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(40768793) Breast Pathology biopsy report

363

1.10

0.21

1.4

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.16

0.21

1.2

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.16

0.21

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

5.6

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3045142) Bone marrow Pathology biopsy report

397

0.91

0.20

1.2

1.3

—

(3013862) HLA-DP [Type]

0.00

0.20

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.20

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.20

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.2

—

(40763590) HLA-DQ beta [Type]

0.00

0.20

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.20

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

187

0.86

0.20

12.1

13.2

nmol/l

716.6

850.0

0.66

176

(3000285) Sodium [Moles/volume] in Blood

1.22

0.20

1.5

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

327

1.10

0.19

1.4

1.5

15.1

27.0

2.31

205

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.24

0.18

1.6

1.3

—

(3003694) ABO and Rh group [Type] in Blood

845

8329

1.02

0.18

1.5

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

142

0.84

0.17

1.1

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

205

1.12

0.17

1.6

1.5

nmol/l

0.2

0.01

160

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.18

0.16

3.6

2.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.13

0.16

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

111

1.17

0.15

1.5

1.3

—

(3006462) Nitrate [Presence] in Urine

130

1.15

0.15

3.8

3.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.77

0.15

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.77

0.15

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.77

0.15

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.77

0.15

1.0

1.1

—

(3011412) CD3 cells [#/volume] in Blood

306

0.91

0.14

2.0

2.4

e9/l

0.7

1.1

2.47

180

(4024509)

276

1.09

0.13

1.5

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

383

1.07

0.13

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

211

0.90

0.13

2.0

2.5

e6/l

415.9

537.3

0.74

182

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

138

0.87

0.13

1.1

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

238

1.09

0.13

2.3

2.5

e6/l

704.7

559.5

—

102

(40761535) Cells panel - Urine sediment

266

2719

0.98

0.13

4.2

3.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

190

0.89

0.13

16.5

18.6

nmol/l

1358.6

1446.7

0.24

184

(3025018) Bordetella pertussis Ab [Titer] in Serum

127

0.87

0.12

1.5

1.2

—

(44806420)

104

1.15

0.12

3.3

2.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.12

1.1

—

(3024263) Appearance of Synovial fluid

210

0.90

0.12

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

127

1230

1.03

0.12

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

249

1.08

0.12

1.1

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

162

1.11

0.11

8.2

12.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

201

1.10

0.11

1.3

2.1

nmol/l

11.9

17.0

2.54

187

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

476

0.94

0.11

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

182

1.10

0.11

6.6

6.0

u/ml

98.0

796.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

898

1.04

0.10

1.7

1.6

iu/ml

0.8

8.5

0.59

181

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

637

0.96

0.10

1.3

u/l

37.5

39.8

0.06

549

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.14

0.10

1.0

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.14

0.10

2.6

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

432

0.95

0.09

1.2

90.7

114.6

3.52

399

(3000492) Spirometry study

304

2993

1.02

0.09

1.4

1.5

—

(3034426) Prothrombin time (PT)

116

1.12

0.09

1.3

—

(3045424) Erythrocytes [Presence] in Urine

527

1.04

0.09

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.12

0.07

6.5

7.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.83

0.07

4.0

7.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.07

0.07

3.1

2.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.02

0.07

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.87

0.06

1.1

—

(4306422)

446

0.96

0.06

1.4

1.2

—

(3002256) Pathology report gross observation

401

4043

0.99

0.05

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

132

1.06

0.02

1.0

1.2

—

(4211845)

142

1.06

0.02

3.8

3.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

107

0.93

0.02

1.9

2.0

—

(4268621)

308

0.97

0.02

2.6

2.4

—

(3023419) Bacteria identified in Sputum by Culture

453

1.02

0.01

1.4

2.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

104

1.06

0.01

1.0

3.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

466

0.99

0.00

1.4

1.2

u/ml

4.1

3.4

0.18

142

(3045683) HLA typing for celiac disease panel - Blood or Tissue

122

0.98

0.00

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

189

1.01

0.00

2.5

3.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

239

1.00

0.00

1.3

1.9

u/field

1.6

1.7

0.07

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

281

1.00

0.00

1.5

1.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

339

1.00

0.00

1.3

1.2

100.1

96.9

0.26

320

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

206

1.02

0.00

2.8

2.9

45.0

36.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

161

1609

1.00

0.00

2.5

2.4

—

(40758292) HTLV I+II Ab panel - Serum

0.89

0.00

1.6

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.92

0.00

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.88

0.00

1.0

1.4

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.01

0.00

1.3

1.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.5

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.98

0.00

3.8

4.8

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.94

0.00

1.8

3.7

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

2.3

—

1.8

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

44.3

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.0

—

0.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.95

0.00

1.8

1.7

—

49.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(4038314)

0.00

0.0

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.93

0.00

1.3

1.2

—

688.0

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.96

0.00

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

0.0

1.0

—

2.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_ALCOLIV and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_ALCOLIV	11.697 [10.45, 13.1]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.049

During the follow-up period (1.1.1998 — 31.12.2019), 3976 out of 7562 females with K11_ALCOLIV died.

Males

Parameter	HR [95% CI]	p-value
K11_ALCOLIV	9.976 [8.99, 11.08]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 11841 out of 19918 males with K11_ALCOLIV died.

Mortality risk

Mortality risk for people of age

years, who have K11_ALCOLIV.

N-year risk	Females	Males
1	1.184%	1.812%
5	5.878%	9.395%
10	15.011%	23.72%
15	26.759%	40.975%
20	41.307%	60.919%

Relationships between endpoints

↥

Index endpoint: K11_ALCOLIV – Alcoholic liver disease

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Alcoholic liver disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints